PTC Therapeutics Statistics
Total Valuation
PTCT has a market cap or net worth of $6.26 billion. The enterprise value is $6.95 billion.
| Market Cap | 6.26B |
| Enterprise Value | 6.95B |
Important Dates
The last earnings date was Thursday, July 30, 2026, after market close.
| Earnings Date | Jul 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PTCT has 82.95 million shares outstanding. The number of shares has decreased by -0.11% in one year.
| Current Share Class | 82.95M |
| Shares Outstanding | 82.95M |
| Shares Change (YoY) | -0.11% |
| Shares Change (QoQ) | +11.51% |
| Owned by Insiders (%) | 2.42% |
| Owned by Institutions (%) | 107.29% |
| Float | 73.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 135.34 |
| PS Ratio | 6.21 |
| Forward PS | 5.26 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.89 |
| EV / EBITDA | 38.41 |
| EV / EBIT | 55.31 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1,870.04
| Current Ratio | 1,870.04 |
| Quick Ratio | 1,870.04 |
| Debt / Equity | n/a |
| Debt / EBITDA | 16.10 |
| Debt / FCF | n/a |
| Interest Coverage | 0.68 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 2.48% |
| Return on Invested Capital (ROIC) | 4.49% |
| Return on Capital Employed (ROCE) | 3.87% |
| Weighted Average Cost of Capital (WACC) | 6.50% |
| Revenue Per Employee | $1.02M |
| Profits Per Employee | -$38,731 |
| Employee Count | 991 |
| Asset Turnover | 0.34 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -28.69M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +53.22% in the last 52 weeks. The beta is 0.53, so PTCT's price volatility has been lower than the market average.
| Beta (5Y) | 0.53 |
| 52-Week Price Change | +53.22% |
| 50-Day Moving Average | 77.19 |
| 200-Day Moving Average | 73.11 |
| Relative Strength Index (RSI) | 40.84 |
| Average Volume (20 Days) | 1,617,337 |
Short Selling Information
The latest short interest is 9.83 million, so 11.86% of the outstanding shares have been sold short.
| Short Interest | 9.83M |
| Short Previous Month | 17.32M |
| Short % of Shares Out | 11.86% |
| Short % of Float | 13.44% |
| Short Ratio (days to cover) | 3.61 |
Income Statement
In the last 12 months, PTCT had revenue of $1.01 billion and -$38.38 million in losses. Loss per share was -$0.47.
| Revenue | 1.01B |
| Gross Profit | 482.83M |
| Operating Income | 116.73M |
| Pretax Income | -67.07M |
| Net Income | -38.38M |
| EBITDA | 180.90M |
| EBIT | 125.60M |
| Loss Per Share | -$0.47 |
Balance Sheet
The company has $2.23 billion in cash and $2.91 billion in debt, with a net cash position of -$683.32 million or -$8.24 per share.
| Cash & Cash Equivalents | 2.23B |
| Total Debt | 2.91B |
| Net Cash | -683.32M |
| Net Cash Per Share | -$8.24 |
| Equity (Book Value) | -165.36M |
| Book Value Per Share | -1.98 |
| Working Capital | 2.23B |
Cash Flow
In the last 12 months, operating cash flow was -$217.95 million and capital expenditures -$8.33 million, giving a free cash flow of -$226.28 million.
| Operating Cash Flow | -217.95M |
| Capital Expenditures | -8.33M |
| Depreciation & Amortization | 54.84M |
| Net Borrowing | -1.61M |
| Free Cash Flow | -226.28M |
| FCF Per Share | -$2.73 |
Margins
Gross margin is 47.86%, with operating and profit margins of 11.57% and -3.80%.
| Gross Margin | 47.86% |
| Operating Margin | 11.57% |
| Pretax Margin | -6.65% |
| Profit Margin | -3.80% |
| EBITDA Margin | 17.93% |
| EBIT Margin | 12.45% |
| FCF Margin | n/a |
Dividends & Yields
PTCT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.11% |
| Shareholder Yield | 0.11% |
| Earnings Yield | -0.61% |
| FCF Yield | -3.61% |
Analyst Forecast
The average price target for PTCT is $96.07, which is 27.21% higher than the current price. The consensus rating is "Buy".
| Price Target | $96.07 |
| Price Target Difference | 27.21% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (3Y) | -2.79% |
| EPS Growth Forecast (3Y) | -8.76% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |